ArticleBrain, behavior, & immunity - health2026
Neurocognitive sequelae following seronegative anti-NMDA receptor encephalitis with ovarian teratoma in a pediatric patient: A six-year follow-up case report.
Article in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the commonest form of autoimmune encephalitis of childhood. However, little information is captured with formal neuropsychological testing. When the pre-illness history is incomplete, it is also hard to judge how much of the residual picture reflects the encephalitis itself rather than an earlier neurodevelopmental vulnerability. Case presentation: We describe the case of an adopted girl who became acutely unwell at 11 years of age, with a rapid neuropsychiatric deterioration, seizures and abnormal movements. A mature ovarian teratoma was found and removed, and the clinical course, serial EEGs and response to immunotherapy supported a diagnosis of probable anti-NMDAR encephalitis. Serum and cerebrospinal fluid (CSF) antibodies were negative, although the samples were taken late and after treatment had begun. She was managed with corticosteroids and intravenous immunoglobulin. Six years on, formal testing showed largely intact verbal comprehension but clear weaknesses in executive function, attention, processing speed and verbal memory. She met criteria for autism spectrum disorder; overall cognitive ability was in the low average range. Conclusion: This case shows how a paraneoplastic, immune-mediated insult to the developing brain can leave a lasting cognitive mark, how easily seronegative disease is missed, and why it is often neuropsychological assessment, rather than imaging, that reveals the residual burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.